These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35093084)
21. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective. Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276 [TBL] [Abstract][Full Text] [Related]
22. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan. Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199 [TBL] [Abstract][Full Text] [Related]
23. Generation of a Danish TTO value set for EQ-5D health states. Wittrup-Jensen KU; Lauridsen J; Gudex C; Pedersen KM Scand J Public Health; 2009 Jul; 37(5):459-66. PubMed ID: 19411320 [TBL] [Abstract][Full Text] [Related]
24. Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off. Paveliu MS; Olariu E; Caplescu R; Oluboyede Y; Niculescu-Aron IG; Ernu S; Vale L Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299864 [TBL] [Abstract][Full Text] [Related]
25. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off. Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582 [TBL] [Abstract][Full Text] [Related]
26. Societal Preferences for EQ-5D Health States from a Brazilian Population Survey. Viegas Andrade M; Noronha K; Kind P; Maia AC; Miranda de Menezes R; De Barros Reis C; Nepomuceno Souza M; Martins D; Gomes L; Nichele D; Calazans J; Mascarenhas T; Carvalho L; Lins C Value Health Reg Issues; 2013 Dec; 2(3):405-412. PubMed ID: 29702778 [TBL] [Abstract][Full Text] [Related]
27. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set. Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730 [TBL] [Abstract][Full Text] [Related]
28. Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS. Svedbom A; Borgström F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Uusküla A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA Qual Life Res; 2018 Mar; 27(3):707-716. PubMed ID: 29235059 [TBL] [Abstract][Full Text] [Related]
29. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China. Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418 [TBL] [Abstract][Full Text] [Related]
30. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Lee YK; Nam HS; Chuang LH; Kim KY; Yang HK; Kwon IS; Kind P; Kweon SS; Kim YT Value Health; 2009; 12(8):1187-93. PubMed ID: 19659703 [TBL] [Abstract][Full Text] [Related]
31. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC; Value Health; 2009; 12(5):750-8. PubMed ID: 19490564 [TBL] [Abstract][Full Text] [Related]
32. Multiplicative modelling of EQ-5D-3L TTO and VAS values. Shafie AA; Vasan Thakumar A Eur J Health Econ; 2020 Dec; 21(9):1411-1420. PubMed ID: 32892230 [TBL] [Abstract][Full Text] [Related]
33. Valuing EQ-5D health states for Sri Lanka. Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA Qual Life Res; 2015 Jul; 24(7):1785-93. PubMed ID: 25543271 [TBL] [Abstract][Full Text] [Related]
34. Interim value set for the EQ-5D-5L in Iran using the Crosswalk method. Ameri H; Safari H; Yousefi M; Bagheri Faradonbeh S; Goudarzi R; Soofi M Med J Islam Repub Iran; 2020; 34():121. PubMed ID: 33437717 [No Abstract] [Full Text] [Related]
35. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary. Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242 [TBL] [Abstract][Full Text] [Related]
36. Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets. Prevolnik Rupel V; Srakar A; Rand K Zdr Varst; 2020 Mar; 59(1):8-17. PubMed ID: 32952698 [TBL] [Abstract][Full Text] [Related]
37. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Feng Y; Devlin N; Herdman M Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956 [TBL] [Abstract][Full Text] [Related]
38. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study. Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899 [TBL] [Abstract][Full Text] [Related]
39. Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in China. Jin X; Liu GG; Gerstein HC; Levine MAH; Guan H; Li H; Xie F Diabetes Metab Res Rev; 2018 Nov; 34(8):e3053. PubMed ID: 30064154 [TBL] [Abstract][Full Text] [Related]
40. Properties of the EQ-5D-3L index distribution when longitudinal data from 27,328 spine surgery procedures are applied to nine national EQ-5D-3L value sets. Joelson A; Sigmundsson FG; Karlsson J Qual Life Res; 2021 May; 30(5):1467-1475. PubMed ID: 33449340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]